Vés al contingut

A Randomized, Double-masked, Multicenter, 3-Arm Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal EYE103 Compared with Intravitreal ranibizumab (0.5mg) in Participants with Diabetic Macular Edema

Obert
  • Codi protocol: EYE-RES-102
  • Codi EudraCT: No aplica
  • Grup de recerca: Oftalmologia
  • Servei: Oftalmologia
  • Investigador/a principal:  Garrido Marin, Marta
  • Malaltia: Malalties de l’ull i dels seus annexos
  • Fase: Fase III